0.2950USD0.00%Mkt Cap: —P/E: —Last update: 2026-05-22
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)6.16M USD
Gross Profit1.88M USD
Net Income (TTM)-14.91M USD
Revenue/Share3.580 USD
Last Price0.2950 USD
Fiscal Year End—
MR Quarter—
Employees57
CountryUS
SectorHealth Care
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.12
EPS (TTM)—
EPS (Forward)—
52W Range
0.2203100% of range0.2950
52W High0.2950 USD
52W Low0.2203 USD
Profitability
Gross Margin30.80%
Oper. Margin-196.95%
EBITDA Margin-163.38%
Profit Margin-244.10%
ROE-204.87%
ROA-136.03%
Growth
Revenue Growth-27.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.33M USD
CapEx (TTM)60.57K USD
FCF Margin-80.06%
FCF Yield—
Net Debt-5.29M USD
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity0.16
Current Ratio2.60
Quick Ratio2.41
Book Value/Sh1.619 USD
Cash/Share1.435 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float4.27M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta-1.19
S&P 52W Chg28.31%
Avg Vol (30d)0
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—